Physiological health indexes predict deterioration and mortality in patients with COVID-19: a comparative study.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
25 02 2022
Historique:
received: 04 11 2021
accepted: 11 02 2022
pubmed: 26 2 2022
medline: 25 3 2022
entrez: 25 2 2022
Statut: ppublish

Résumé

Old age is a crucial risk factor for severe coronavirus disease 2019 (COVID-19), with serious or fatal outcomes disproportionately affecting older adults compared with the rest of the population. We proposed that the physiological health status and biological age, beyond the chronological age itself, could be the driving trends affecting COVID-19 severity and mortality. A total of 155 participants hospitalized with confirmed COVID-19 aged 26-94 years were recruited for the study. Four different physiological summary indices were calculated: Klemera and Doubal's biological age, PhenoAge, physiological dysregulation (PD; globally and in specific systems), and integrated albunemia. All of these indices significantly predicted the risk of death (p < 0.01) after adjusting for chronological age and sex. In all models, men were 2.4-4.4-times more likely to die than women. The global PD was shown to be a good predictor of deterioration, with the odds of deterioration increasing by 41.7% per 0.5-unit increase in the global PD. As for death, the odds also increased by 68.3% per 0.5-unit increase in the global PD. Our results are partly attributed to common chronic diseases that aggravate COVID-19, but they also suggest that the underlying physiological state could capture vulnerability to severe COVID-19 and serve as a tool for prognosis that would, in turn, help inpatient management.

Identifiants

pubmed: 35213841
pii: 203915
doi: 10.18632/aging.203915
pmc: PMC8908924
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1611-1626

Références

Mech Ageing Dev. 2006 Mar;127(3):240-8
pubmed: 16318865
Aging (Albany NY). 2020 May 29;12(10):9959-9981
pubmed: 32470948
Aging (Albany NY). 2020 Mar 31;12(8):6492-6510
pubmed: 32229705
PLoS One. 2015 Apr 13;10(4):e0122541
pubmed: 25875923
J Gerontol A Biol Sci Med Sci. 2021 Jul 13;76(8):e133-e141
pubmed: 33684206
Ageing Res Rev. 2021 May;67:101308
pubmed: 33621704
Mech Ageing Dev. 2013 Mar;134(3-4):110-7
pubmed: 23376244
J Gerontol A Biol Sci Med Sci. 2013 Jun;68(6):667-74
pubmed: 23213031
Front Immunol. 2020 Aug 07;11:1748
pubmed: 32849623
PLoS One. 2015 Mar 11;10(3):e0116489
pubmed: 25761112
Aging (Albany NY). 2018 Apr 18;10(4):573-591
pubmed: 29676998
Arch Gerontol Geriatr. 2021 Mar-Apr;93:104324
pubmed: 33352430
Aging (Albany NY). 2020 Apr 8;12(8):6490-6491
pubmed: 32268300
Aging Cell. 2015 Dec;14(6):1103-12
pubmed: 26416593
Exp Gerontol. 2014 Sep;57:203-10
pubmed: 24802990

Auteurs

Irina Strazhesko (I)

Russian Clinical Research Center for Gerontology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow 129226, Russian Federation.

Olga Tkacheva (O)

Russian Clinical Research Center for Gerontology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow 129226, Russian Federation.

Daria Kashtanova (D)

Russian Clinical Research Center for Gerontology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow 129226, Russian Federation.

Mikhail Ivanov (M)

Russian Clinical Research Center for Gerontology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow 129226, Russian Federation.

Vladislav Kljashtorny (V)

Russian Clinical Research Center for Gerontology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow 129226, Russian Federation.

Antonina Esakova (A)

Russian Clinical Research Center for Gerontology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow 129226, Russian Federation.

Maria Karnaushkina (M)

Federal State Autonomous Educational Institution of Higher Education "Peoples' Friendship University of Russia" (RUDN University), Department of Internal Medicine, Moscow 117198, Russian Federation.

Cassandra Guillemette (C)

PRIMUS Research Group, Department of Family Medicine, University of Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada.

Amber Hewett (A)

PRIMUS Research Group, Department of Family Medicine, University of Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada.

Véronique Legault (V)

PRIMUS Research Group, Department of Family Medicine, University of Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada.

Lilit Maytesian (L)

Russian Clinical Research Center for Gerontology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow 129226, Russian Federation.

Maria Litvinova (M)

Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow 119991, Russian Federation.
The Loginov Moscow Clinical Scientific Center of Moscow Health Department, Moscow 111123, Russian Federation.

Alan Cohen (A)

PRIMUS Research Group, Department of Family Medicine, University of Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada.
Research Center on Aging, Sherbrooke, Quebec J1H 4C4, Canada.
Research Center of Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada.

Alexey Moskalev (A)

Russian Clinical Research Center for Gerontology, Pirogov Russian National Research Medical University of the Ministry of Healthcare of the Russian Federation, Moscow 129226, Russian Federation.
Institute of Biology, Komi Science Center of Russian Academy of Sciences, Syktyvkar 167000, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH